Skip to content

Research at St Andrews

Anti-Müllerian hormone (AMH) in the diagnosis of menstrual disturbance due to polycystic ovarian syndrome

Research output: Contribution to journalArticle

Author(s)

A Abbara, P C Eng, M Phylactou, S A Clarke, T Hunjan, R Roberts, S Vimalesvaran, G Christopoulous, R Islam, K Purugganan, A M Comninos, G H Trew, R Salim, A Hramyka, L Owens, Thomas William Kelsey, W Dhillo

School/Research organisations

Abstract

Introduction: Polycystic ovarian syndrome (PCOS) is a leading cause of female subfertility worldwide, however due to the heterogeneity of the disorder, the criteria for diagnosis remains subject to conjecture. In the present study, we evaluate the utility of serum Anti-Müllerian Hormone (AMH) in the diagnosis of menstrual disturbance due to PCOS.

Method: Menstrual cycle length, serum AMH, gonadotropin and sex-hormone levels, total antral follicle count (AFC), body mass index (BMI) and ovarian morphology on ultrasound were analyzed in a cohort of 187 non-obese women, aged 18–35 years, screened for participation in a clinical trial of fertility treatment between 2013 and 2016 at a tertiary reproductive endocrine center.

Results: Serum AMH was higher in women with menstrual disturbance when compared to those with regular cycles (65.6 vs. 34.8 pmol/L; P < 0.0001). The odds of menstrual disturbance was increased 28.5-fold (95% CI 3.6–227.3) in women with serum AMH >60 pmol/L, in comparison to those with an AMH < 15 pmol/L. AMH better discriminated women with menstrual disturbance (area under ROC 0.77) from those with regular menstrual cycles than AFC (area under ROC 0.67), however the combination of the two markers increased discrimination than either measure alone (0.83; 95% CI 0.77–0.89). Serum AMH was higher in women with all three cardinal features of PCOS (menstrual disturbance, hyperandrogenism, polycystic ovarian morphology) when compared to women with none of these features (65.6 vs. 14.6 pmol/L; P < 0.0001). The odds of menstrual disturbance were increased by 10.7-fold (95% CI 2.4–47.1) in women with bilateral polycystic morphology ovaries than those with normal ovarian morphology. BMI was a stronger predictor of free androgen index (FAI) than either AMH or AFC.

Conclusion: Serum AMH could serve as a useful biomarker to indicate the risk of menstrual disturbance due to PCOS. Women with higher AMH levels had increased rates of menstrual disturbance and an increased number of features of PCOS.
Close

Details

Original languageEnglish
Article number656
Number of pages11
JournalFrontiers in Endocrinology
Volume10
Early online date26 Sep 2019
DOIs
Publication statusPublished - 26 Sep 2019

    Research areas

  • Polycystic ovarian syndrome (PCOS), Antral follicle count (AFC), Anti-Mullerian Hormone (AMH), Amenorrhea, Oligomenorrhea, Hyperandrogenaemia

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. FSH requirements for follicle growth during controlled ovarian stimulation

    Abbara, A., Patel, A. H., Hunjan, T., Clarke, S., Chia, G., Eng, P. C., Phylactou, M., Comninos, A., Lavery, S., Trew, G., Salim, R., Rai, R., Kelsey, T. W. & Dhillo, W., 27 Aug 2019, In : Frontiers in Endocrinology. 10, 11 p., 579.

    Research output: Contribution to journalArticle

  2. Representation learning for minority and subtle activities in a smart home environment

    Rosales Sanabria, A., Kelsey, T. W. & Ye, J., 22 Jul 2019, Proceedings of the IEEE International Conference on Pervasive Computing and Communications (PerCom 2019). IEEE Computer Society, 7 p. 8767417

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  3. Characterization of follicles in girls and young women with Turner syndrome who underwent ovarian tissue cryopreservation

    Mamsen, L. S., Charkiewicz, K., Anderson, R. A., Telfer, E. E., McLaughlin, M., Kelsey, T. W., Kristensen, S. G., Gook, D. A., Ernst, E. & Andersen, C. Y., Jun 2019, In : Fertility and Sterility. 111, 6, p. 1217-1225.e3 12 p.

    Research output: Contribution to journalArticle

  4. Perinatal complications in female survivors of cancer: a systematic review and meta-analysis

    van der Kooi, A. L., Kelsey, T. W., van den Heuvel-Eibrink, M., Laven, J. S. E., Wallace, W. H. B. & Anderson, R. A., Apr 2019, In : European Journal of Cancer. 111, p. 126-137

    Research output: Contribution to journalArticle

  5. Fertility preservation by ovarian tissue freezing in patients with genetic and chromosomal disorders

    Mamsen, L. S., Anderson, R. A., Telfer, E. E., McGlaughlin, M., Kelsey, T. W., Ernst, E., Macklon, K. T., Lund, A. M., Kristensen, S. G., Gook, D. A. & Andersen, C. Y., 2019.

    Research output: Contribution to conferenceAbstract

Related by journal

  1. Frontiers in Endocrinology (Journal)

    Tom Kelsey (Member of editorial board)
    Feb 2018Jan 2022

    Activity: Publication peer-review and editorial work typesEditor of research journal

Related by journal

  1. FSH requirements for follicle growth during controlled ovarian stimulation

    Abbara, A., Patel, A. H., Hunjan, T., Clarke, S., Chia, G., Eng, P. C., Phylactou, M., Comninos, A., Lavery, S., Trew, G., Salim, R., Rai, R., Kelsey, T. W. & Dhillo, W., 27 Aug 2019, In : Frontiers in Endocrinology. 10, 11 p., 579.

    Research output: Contribution to journalArticle

  2. Follicle size on day of trigger most likely to yield a mature oocyte

    Abbara, A., Vuong, L. N., Ho, V. N. A., Clarke, S. A., Jeffers, L., Comninos, A. N., Salim, R., Ho, T. M., Kelsey, T. W., Trew, G. H., Humaiden, P. & Dhillo, W. S., 25 Apr 2018, In : Frontiers in Endocrinology. 9, 11 p., 193.

    Research output: Contribution to journalArticle

  3. Insulin-like growth factor binding proteins of teleost fishes

    Garcia de la Serrana, D. & Macqueen, D. J., 12 Mar 2018, In : Frontiers in Endocrinology. 9, 12 p., 80.

    Research output: Contribution to journalReview article

ID: 261009300

Top